AcceleratingConceivingDesigningTestingPositioning
novel technologies for impact
Positive future outcomes in global health require reimagining the paradigms and platforms available today.
What if all diseases could be detected accurately, simply, and quickly without visiting a clinic?
What if diseases could be prevented from transmission and be treated more quickly and effectively?
What if Human Immunodeficiency Virus (HIV) and Sickle Cell Disease (SCD) could be cured with a single shot?
What if AI could be trained on high quality and highly curated datasets to bring drugs with worldwide impact to market safely, rapidly, and cheaply?
What if large-scale manufacturing could address food insecurity while protecting the environment and enabling local, affordable production of drugs?
The Accelerator works across sectors and geographies, building strong partnerships to develop fundamentally novel platforms and products with the capacity to transform health outcomes in low- and middle-income countries.
Impact Model
The Accelerator’s impact model is powered by the confluence of its technical and scientific expertise, position as a global funder, and the strength of its partnerships.
-
Conceive
The Accelerator envisions and validates new investment domains for the creation of novel platform technologies with the potential to shift current paradigms and accelerate progress in global health at scale. -
Invest
Working with strategic partners, the Accelerator identifies investment opportunities to fund complementary and competing entities in parallel. -
Prove
The Accelerator actively manages investments through proof of concept in order to position each domain for impact. -
Enable
The Accelerator works with strategic pathway partners to create the enabling environments and incentives required for uptake of funded innovations.
Investment Model
The Accelerator builds capability-specific portfolios by funding a mix of complementary and competing entities to develop cutting-edge scientific and technological innovations that could fundamentally advance global health gaps.
Multinationals
The Accelerator makes grants on a 50/50 cost share basis to multinational corporations with the expertise, resources, and desire to incubate a new R&D area that can transition to impactful, mission-driven, and commercial products at scale.
Funding Mechanisms:
Grants
Biotechs
The Accelerator invests in biotechs, from new academic spinouts to more established companies, at seed funding stages and beyond, taking an approach that funds competing or complementary technologies within each domain to support success.
Funding Mechanisms:
Grants & Equity Investments
Researchers
The Accelerator funds academic research to advance the field, prove basic scientific and technical principles that power the team’s portfolios, and determine the enabling environment necessary to support uptake and impact within a technology domain.
Funding Mechanisms:
Grants & Contracts